No valuation for Biomakers is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($20.0M) and the funding record below are the closest available signals.
- ·The complete investor list: 12 names
- ·Watch Biomakers: the Monday email on marks, rounds and moves
Biomakers funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2024 | Early Stage VC | $5.9M | ▮ | ▮ |
Membership and data by Private Market View
How much has Biomakers raised?
Biomakers has raised $20 million in total; 1 of its rounds is on record. The largest on record was a $5.9 million early-stage round in Jan 2024.
Biomakers has filed 2 Form Ds with the SEC since 2024, most recently in Feb 2025 ($2.4 million sold to 5 investors).
How Biomakers's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Biomakers, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Biomakers
- How much has Biomakers raised?
- Biomakers has raised $20.0M in total funding across 1 recorded rounds.
- When did Biomakers last raise?
- Biomakers last raised in Jan 2024 (Early Stage VC), raising $5.9M.